top of page

Health Economics

 Market Access 

EU, Americas and Canada

Middle East, Africa & Asia-Pacific Regions

Areas of Expertise​

Reimbursement Support

   Model Strategy &        Design

Systematic Reviews

Training & Courses

health econ icon.png

 Health
Economics

Health Economic Modelling

Survival Extrapolation

Mapping EQ-5D

Statistical Programming for Health Economic Modelling

Budget Impact Modelling

Cost Effectiveness Analysis

Indirect Comparisons / MAIC

Real World Evidence Generation

hta icon.png

Reimbursement Agency Support

HTA & Reimbursement Submissions

Post Submission

Reports

pexels-vlada-karpovich-7433822_edited.jp

​At R-S-S, our HTA experts are equipped to deal with the ever changing regulatory and reimbursement environment. We understand how to coordinate across differing markets and disease areas.

pexels-fauxels-3183197.jpg

R-S-S brings its years of experience from those who have had first-hand experience working in major reimbursement agencies (e.g. NICE, IQWiG, PBAC, CADTH, CESP, SNS, EUnetHTA) to help solve the unique and complex challenges and requirements clients face throughout the reimbursement process.

Our health economics and health technology assessment teams are exceptional and have had a great success rate in all projects undertaken by R-S-S.

With innovation at our core,  R-S-S can help you achieve market access for your product through our commitment to quality and teamwork. 

Our team will be there to support and offer guidance every step of the way in your journey of research, product development and product deployment.

Africa.png
Europe.png

'Our Global Prescence'

Australia.png
Asia.png
North Ameirca.png

Experience in Middle East, Africa and Asia-Pacific Markets

The landscape of market access in the Middle East, Africa and Asia-Pacific is undergoing a significant transformation. At R-S-S, our specialized pharma market access consulting services empower our clients to develop effective strategies for market entry, engage with payers, and communicate value across the Middle East, Africa and Asia-Pacific.

pexels-olly-3760067_edited.jpg

Each country in Asia has its own unique regulatory framework. Our experts also have experience in dealing with these markets, working with regulatory bodies like National Medical Products Administration (NMPA),Pharmaceuticals and Medical Devices Agency (PMDA) and Ministry of Food and Drug Safety of the Republic of Korea (MFDS) etc.

Partner with us to navigate the evolving market access landscape and achieve success in the Middle East and Asia.

“Unlocking Success: The R-S-S Difference”

Proven Excellence

Timely Project Delivery

Optimized Costs

Transparent Project Visibility

Dedicated Customer Support

Payer Engagement Roadmaps

Our expertise ensures seamless collaboration with payers, facilitating successful market entry.

Market Vigilance

Staying informed about reimbursement developments is our priority. By anticipating roadblocks and risks, we keep projects on track.

Value Communication Strategies

We help clients articulate their value proposition effectively, bridging the gap between reimbursement agency requirements and stakeholders.

Strategic Insights

We provide tailored market access strategies that align with the unique dynamics of each region.

Headquarters for Asia Region

Suite 206,

Second Floor, Gaylord Apartment Building,

KDA Scheme-1

Tipu Sultan Road

Karachi

bottom of page